D
David Spiegel
Researcher at Stanford University
Publications - 838
Citations - 50967
David Spiegel is an academic researcher from Stanford University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 106, co-authored 733 publications receiving 46276 citations. Previous affiliations of David Spiegel include Tel Aviv University & University of Adelaide.
Papers
More filters
Journal ArticleDOI
Effects of Psychosocial Support on Patients with Metastatic Breast Cancer
TL;DR: Evidence that psychosocial support may influence the progression of cancer, as indicated by differences in length of survival is reviewed, as well as the limitations of these theories and suggestions for future research.
Journal Article
New uses of hypnosis in the treatment of posttraumatic stress disorder.
David Spiegel,Etzel Cardeña +1 more
TL;DR: New uses of hypnosis in the psychotherapy of PTSD victims involve coupling access to the dissociated traumatic memories with positive restructuring of those memories, which can be used to help patients face and bear a traumatic experience.
Journal ArticleDOI
Using the Science of Psychosocial Care to Implement the New American College of Surgeons Commission on Cancer Distress Screening Standard
TL;DR: The evidence linking depression-one aspect of distress-and cancer outcomes is reviewed to highlight the profound influence psychosocial care delivery can have on promoting medical outcomes and quality cancer survivorship.
Journal ArticleDOI
Hypnotizability and psychopathology.
TL;DR: All of the diagnosed patients (those with thought disorder, affective disorder, generalized anxiety, and miscellaneous disorders) were significantly less hypnotizable than the nonpatient comparison group; this effect was unrelated to age or medication differences.
Journal ArticleDOI
Higher vagal activity as related to survival in patients with advanced breast cancer: an analysis of autonomic dysregulation
Janine Giese-Davis,Frank H. Wilhelm,Rie Tamagawa,Oxana Palesh,Eric Neri,Craig Barr Taylor,Helena C. Kraemer,David Spiegel +7 more
TL;DR: Vagal activity of patients with MRBC strongly predicted their survival, extending the known predictive window of HF-HRV in cancer beyond palliative care.